Sildenafil Citrate Market Outlook:
Sildenafil Citrate Market size was valued at USD 3.9 billion in 2025 and is projected to reach USD 6.7 billion by the end of 2035, rising at a CAGR of 5.7% during the forecast period, i.e., 2026 to 2035. In 2026, the industry size of sildenafil citrate is estimated at USD 4.1 billion.
The sildenafil citrate market is witnessing tremendous growth, shaped by its large patient pool affected by erectile dysfunction. For instance, the NLM study in January 2024 depicts that 150 million men around the globe have erectile dysfunction. The U.S. alone accounts for more than 52% of ED-associated prevalence, and this number increases with the rise in age. Further, this has encouraged investment in available efficient treatment procedures for such disorders. On the other hand, the supply chain for this market is global and highly consolidated.
The growing prevalence of lifestyle diseases such as hypertension, diabetes, and cardiovascular disorders has fueled rising erectile dysfunction cases worldwide, boosting demand for sildenafil citrate. As per the CDC report in July 2025, the deaths due to cardiovascular disease are registered at 32% globally. Further, many people are seeking therapy as a result of changing social norms and a decline in the stigma associated with sexual health. The availability of low-cost generics further expands consumer reach. Trade data from the U.S. International Trade Commission shows the large import and export volumes, while generics continue to ease consumer costs.
